<div id="readability-page-1">Stock purchases draw scrutiny: Trump acquired up to $680,000 in Eli Lilly shares as federal policies supported its obesity drug portfolio. Trust concerns emerge: Legal ethicists warn the timing could undermine confidence, though Trump’s team says trades are independently managed. Broader trading shift: The Lilly buys are part of a pivot from bonds to hundreds of stock trades in sectors tied to administration policies.</div>

禮來

2 倍做多 LLY ETF - Direxion

1 倍做空 LLY ETF - Direxion

<p>特朗普在有利的聯邦政策支持其肥胖藥物的情況下，購買了高達 68 萬美元的禮來股票。法律倫理學家對這一時機表示擔憂，認為可能會削弱公眾信任，儘管特朗普的團隊聲稱這些交易是獨立管理的。這一舉動反映了從債券轉向與政府政策相關的多項股票交易的更廣泛趨勢</p>

特朗普因政策對禮來的藥物有利而購買了禮來的股票